TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Kårhuset Pharmen AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
290
|
720
|
583 |
| Financial expenses |
18
|
44
|
139 |
| Earnings before taxes |
3,108
|
-49
|
-265 |
| EBITDA |
2,920
|
170
|
150 |
| Total assets |
4,966
|
7,235
|
7,230 |
| Current assets |
4,966
|
746
|
592 |
| Current liabilities |
921
|
177
|
159 |
| Equity capital |
4,045
|
6,199
|
6,216 |
| - share capital |
16
|
17
|
4,009 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.5%
|
85.7%
|
86.0% |
| Turnover per employee |
290
|
720
|
583 |
| Profit as a percentage of turnover |
1071.7%
|
-6.8%
|
-45.5% |
| Return on assets (ROA) |
62.9%
|
-0.1%
|
-1.7% |
| Current ratio |
539.2%
|
421.5%
|
372.3% |
| Return on equity (ROE) |
76.8%
|
-0.8%
|
-4.3% |
| Change turnover |
-406
|
134
|
-50 |
| Change turnover % |
-58%
|
23%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.